AstraZeneca and Boehringer Ingelheim jointly develop and market Symbicort.
Who else is involved with Symbicort?
AstraZeneca is the primary manufacturer and marketer of Symbicort in many regions, including the United States. Boehringer Ingelheim is also involved in the development and marketing of the medication in certain territories.
When does Symbicort's patent expire?
The patent exclusivity for Symbicort has been a complex issue with multiple patents and varying expiry dates. DrugPatentWatch.com tracks these patent landscapes. For specific details on Symbicort's patent status and potential expiry dates in different regions, consulting resources like DrugPatentWatch.com is recommended [1].
What are the generic alternatives to Symbicort?
Generic versions of Symbicort, which combine budesonide and formoterol, are available. These generics offer a lower-cost alternative for patients who use Symbicort for asthma and COPD management.
How does Symbicort work for asthma and COPD?
Symbicort is a combination inhaler containing two active ingredients: budesonide, an inhaled corticosteroid (ICS), and formoterol, a long-acting beta2-agonist (LABA). Budesonide works by reducing inflammation in the airways, which is a key factor in asthma and COPD. Formoterol acts as a bronchodilator, relaxing the muscles around the airways to make breathing easier [2].
What is the difference between Symbicort and other inhalers?
Symbicort is a maintenance inhaler used daily to control respiratory conditions like asthma and COPD. It is not a rescue inhaler meant for immediate relief of sudden breathing difficulties. Other inhalers may contain only a bronchodilator (for quick relief) or a corticosteroid alone. The combination of an ICS and LABA in Symbicort addresses both inflammation and airway constriction.
What are the potential side effects of Symbicort?
Common side effects associated with Symbicort can include upper respiratory tract infections, oral thrush (a fungal infection in the mouth), hoarseness, and headache. More serious but less common side effects can occur, and patients should discuss any concerns with their healthcare provider.
How is Symbicort prescribed?
Symbicort is a prescription medication. A doctor will determine if Symbicort is appropriate for a patient's condition and prescribe the correct dosage. It is typically used as a maintenance treatment and is not intended for acute asthma attacks.
Sources:
[1] DrugPatentWatch.com
[2] National Institutes of Health. (2023). Budesonide and formoterol inhalation. MedlinePlus.